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ABSTRACT Whole-genome sequencing of trimethoprim-resistant Escherichia coli
strains MF2165 and PF9285 from healthy Swiss fattening calves revealed a so far un-
characterized dihydrofolate reductase gene, dfrA36. Functionality and association
with trimethoprim resistance were demonstrated by cloning and expressing dfrA36
in E. coli. The DfrA36 protein showed the closest amino acid identity (49.4%) to
DfrA20 from Pasteurella multocida and to the Dfr determinants DfrG (41.2%), DfrD
(40.8%), and DfrK (40.0%) found in Gram-positive bacteria. The dfrA36 gene was inte-
grated within a ﬂorfenicol/chloramphenicol-sulfonamide resistance ISCR2 element
(ﬂoR-ISCR2-dfrA36-sul2) next to a Tn21-like transposon that contained genes with re-
sistance to sulfonamides (sul1), streptomycin (aadA1), gentamicin/tobramycin/kana-
mycin (aadB), and quaternary ammonium compounds (qacEΔ1). A search of GenBank
databases revealed that dfrA36 was present in 26 other E. coli strains from different
origins as well as in Acinetobacter.
IMPORTANCE The presence of dfrA36 associated with ISCR2 in Escherichia coli from
animals, as well as its presence in other E. coli strains from different sources and
countries and in Acinetobacter, highlights the global spread of this gene and its po-
tential for further dissemination. The genetic link of ISCR2-dfrA36 with other antibi-
otic and disinfectant resistance genes showed that multidrug-resistant E. coli may be
selected and maintained by the use of either one of several antimicrobials.
KEYWORDS Escherichia coli, animals, antibiotic resistance, gene cassettes,
trimethoprim
Trimethoprim is a synthetic folic acid antagonist that was introduced as an antimi-crobial drug in human and veterinary medicine in the late 1960s. It is most
commonly used in combination with sulfonamides: both antibiotics sequentially inhibit
bacterial synthesis of tetrahydrofolic acid, which is a cofactor essential for the synthesis
of thymidine and purine, the fundamental bases of DNA and RNA (1–4). Sulfonamides
are analogues of para-aminobenzoic acid (PABA) and compete with PABA to bind to
the dihydropteroate synthase (DHPS), thereby inhibiting the synthesis of dihydrofolic
acid. Trimethoprim binds to the dihydrofolate reductase (DHFR), thereby blocking the
conversion of dihydrofolic acid into tetrahydrofolic acid (1, 2). The use of trimethoprim/
sulfonamides in both veterinary and human medicine has selected for a resistant
bacterial population. In Switzerland, 28% of the Escherichia coli strains isolated from
humans and up to 25% of E. coli strains from cattle and pigs have been reported to be
resistant to the combination of these antimicrobials (5).
Resistance to sulfonamides and trimethoprim has been associated with ﬁve main
mechanisms, including (i) a permeability barrier, (ii) a naturally insensitive intrinsic
DHFR, (iii) spontaneous chromosomal mutations in the intrinsic DHPS (folP) and DHFR
(folA) genes involved in the folic acid pathways, (iv) increased production of the
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sensitive target enzyme by upregulation of gene expression or gene duplication, and
(v) the acquisition of alternative DHPS (sul) and DHFR (dfr) genes with integrons,
plasmids, and transposons (6, 7). To date, three different alternative sul genes (sul1, sul2,
and sul3) and 40 different types of alternative dfr genes have been described in
Gram-positive and Gram-negative bacteria (8–10). However, the trimethoprim resis-
tance mechanism remained unknown for 8 of 56 trimethoprim-resistant E. coli strains
isolated from rectal swabs of healthy veal calves in 2017 in Switzerland (11). We
selected two genetically diverse E. coli strains (MF2156 and PF9285) from two different
farms based on rep-PCR proﬁle to further investigate the nature of the trimethoprim
resistance in these strains. The whole-genome sequences of both strains were screened
for DHFR homologs followed by proof of functionality.
Identiﬁcation and localization of a new DHFR. Genomic DNA was extracted using
the DNeasy blood and tissue kit (Qiagen, Inc., Venlo, The Netherlands), and puriﬁed
using the AMPure XP PCR puriﬁcation system (Beckman Coulter Life Sciences, India-
napolis, IN). DNA was sequenced on an Illumina HiSeq platform (2 150 paired ends)
(Euroﬁns, Constance, Germany) and on a R9.4 SpotON ﬂow cell and library kit (Oxford
Nanopore Technologies, Oxford, United Kingdom) to obtain long reads and facilitate
genome assembly. Genome assembly and read mapping of the Illumina reads against
the MinION scaffolds were performed as previously described (12). Analyses of the
complete genome using RESFinder 3.1 (Center for Genomic Epidemiology, DTU, Den-
mark) (20% coverage, 30% identity) conﬁrmed the absence of any known acquired dfr
gene in both strains MF2156 and PF9285. Comparison of the chromosomal folA gene
with that of the trimethoprim-susceptible E. coli strain K-12 MG1655 (GenBank acces-
sion no. NC_000913) showed no mutation in this gene in both strains, suggesting the
presence of an alternative mechanism. Search for a possible new acquired dfr gene
within the complete genomes of MF2156 and PF9285 using blastx (https://blast.ncbi
.nlm.nih.gov/) and DfrA1 (NCBI accession no. CAA25445) as the reference revealed the
presence of a 177-amino-acid DHFR homologue (513 bp) in both strains. This putative
new DHFR shared the closest amino acid identity (49.4%) with DfrA20 from Pasteurella
multocida (GenBank accession no. CAE53424) (13) and was next closely related to Dfr
proteins DfrD, DfrG, and DfrK, which have been identiﬁed so far only in Gram-positive
bacteria (Fig. 1). The new gene was named dfrA36 following the nomenclature used for
Gram-negative bacteria (9).
The dfrA36 gene was located on a 22,977-bp fragment integrated in the same
location of the chromosome in both E. coli strains MF2156 and PF9285. Both ends of the
integrated element were identiﬁed by comparative analysis of sequences of strains
MF2156 and PF9285 with those from E. coli strain PSU078, which shared an identical
ﬂanking region (GenBank accession no. CP012112). The fragment was delimited by a
truncated ISCR2 (ΔISCR2) interrupting a putative restriction endonuclease subunit S
gene on one side and by a sul2 gene interrupting a putative Tat pathway signal
sequence protein gene on the other side. The fragment contains an ISCR2 element
carrying the dfrA36 gene, the ﬂorfenicol/chloramphenicol export gene ﬂoR, and the
sulfonamide resistance gene sul2 (ﬂoR-ISCR2-dfrA36-sul2) and a 14,231-bp Tn21-like
element (Fig. 2). Given the comparison to PSUO78, it is likely that the dfrA36 region and
the Tn21-like element were mobilized into the chromosome either simultaneously or
separately by homologous recombination. The dfrA36 gene was integrated with a gene
of the Rrf2 transcriptional regulator family into the phosphoglucosamine mutase gene
glm of a ﬂoR-ISCR2-sul2 element, which has been previously reported in Stenotroph-
omonas maltophilia (14, 15). Integration of the dfrA36-rrf2 fragment split the glm gene
into two pieces, generating a duplication of the ACGT integration sequence (Fig. 2). The
dfrA36-rrf2 has likely been trapped by the gene-capturing machinery described for ISCR
elements and mobilized by rolling circle transposition, but dfrA36 does not seem to be
a single cassette as many other dfr genes are (14, 16, 17). The Tn21-like element
contained the characteristic features deﬁning the Tn21 subgroup with a transposase
gene, tnpA, a resolvase gene, tnpR, in the same orientation, the res sites preceding tnpR,
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FIG 1 Phylogenetic tree of all known Dfr proteins, including the novel protein DfrA36. The tree was obtained by multiple alignment of amino
acid sequences (without fast alignment) and the UPGMA clustering method with Jukes and Cantor correction using Bionumerics 7.6 (Applied
Maths, Kortrijk, Belgium): multiple alignment with an open gap penalty (OG) of 100%, a unit gap penalty (UG) of 0%, a gap penalty of 100%, and
1,000 bootstrap values (nodes). Scala results are shown as distances. The percentages of amino acid sequence identity between DfrA36 and other
Dfr proteins were determined by multiple sequence alignment with clustalW 2.1 (cost matrix Blosum) using Geneious prime 2019.1.1 (Biomatters,
Ltd., Auckland, New Zealand).
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and two 38-bp inverted repeats at both ends (18, 19). It also contained a class I integron
In290 (INTEGRALL database), including the integrase gene intI1, the sulfonamide resis-
tance gene sul1, the streptomycin/spectinomycin resistance gene aadA1 [ant(3)-Ia], the
gentamicin/tobramycin/kanamycin resistance gene aadB [ant(2)-Ia], the quaternary
ammonium compound (QAC) efﬂux transporter gene qacEΔ1, as well as the trans-
posase genes of IS1326 and of a new transposase gene related to IS3. Duplication of
ISCR2 sequences suggests that insertion and movement of the different pieces of the
element may have also occurred by homologous recombination (Fig. 2).
As expected by its chromosomal location and genetic context, transferability of the
dfrA36 gene could not be observed experimentally by ﬁlter mating using strains
MF1256 and PF9285 as donors and the rifampin-, sodium azide-resistant strain E. coli
J53dR as the recipient (20). Selection was performed on Mueller-Hinton (MH) agar
plates containing trimethoprim (30 g/ml) with either sodium azide (100 g/ml) or
rifampin (50 g/ml) for 48 h at 37°C.
Expression of dfrA36 in E. coli. Functionality and association of dfrA36 with
trimethoprim resistance were determined by cloning an 878-bp region containing the
FIG 2 Schematic representation of the integration of dfrA36 into ISCR2-sul2 (ISCR2-dfrA36-sul2) and its genetic
linkage with a Tn21-like transposon in E. coli PF9285. Shown are open reading frames (ORFs) and functions.
The ORF of DfrA36 is indicated by a magenta arrow and represents the dehydrofolate reductase for
trimethoprim resistance. ORFs of other antibiotic resistance proteins are in red: Sul1 and Sul2, dihydropteroate
synthase for sulfonamide resistance; AadA1, streptomycin/spectinomycin 3-adenylyltransferase ANT(3)-Ia;
AadB, aminoglycoside-2-O-nucleotidyltransferase ANT(2)-Ia; FloR, ﬂorfenicol/chloramphenicol export pro-
tein; QacEΔ1, quaternary ammonium compound efﬂux transporter; aminoglycoside 3-N-acetyltransferase.
ORFs of hypothetical proteins are represented by gray arrows. ORFs of transposases associated with insertion
sequences (IS), transposon Tn21 (Tnp), as well as integrase (IntI1) and resolvase (Res) are indicated by green
arrows, except for the ORFs of ISCR2 and ΔISCR2, which are indicated in deep sky blue. The res sites I, II, and
III of Tn21 as well as the oriIS and terIS sequences of ISCR2 are indicated in purple. The putative phosphog-
lucosamine mutase Glm as well as the 3=-end truncated part (Glm=) and the 5=-end truncated part (=Glm) are
indicated in orange. ORFs representing the core genomes of strains PF9285 (GenBank accession no. CP038791)
and PSUO78 (GenBank accession no. CP012112) are indicated by black arrows with Tat as a putative Tat
pathway signal sequence protein and ORF1 as a putative restriction endonuclease subunit S protein. Arrows
with black diamonds attached indicate the limit of the 22,977-bp region in PF9285 as determined by the end
of common sequences between the E. coli PF9285 and PSUO78 chromosomes interrupted by ΔISCR2 on the
left side and by the beginning of the sul2 core sequences on the right side (positions 989354 to 1012331 in
CP038791). Inverted repeats of the Tn21 element are indicated by oval arrows with black circles (IV-L,
GGGGGCACCTCAGAAAACGGAAAATAAAGCACGCTAAG; and IV-R, CTTAGCGTGCTTTATTTTCCGTTTTCTGAGACG
ACCCC). Direct repeats of ACGT duplicated by the insertion of the rrf2-dfrA36 fragment into pgm are indicated
in white boxes. The ﬁgure was created using Microsoft PowerPoint and Easyﬁg 2.2.2 (22).
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513-bp dfrA36 gene and a 265-bp region upstream of the dfrA36 start codon. This
fragment was ampliﬁed by PCR using Phusion high-ﬁdelity DNA polymerase (Thermo
Fisher Scientiﬁc, Waltham, MA) and primers dfrA36-F (5=-TGGTGCGCAAATATTTCGGC-
3=) and dfrA36-R (5=-ACGTTAACCCGAAAAAGCGA-3=) (annealing temperature, 56°C;
extension time, 30 s) and cloned into the PCR-Blunt II-TOPO vector following the
manufacturer’s instructions (Zero blunt TOPO PCR cloning kit; Thermo Fisher Scientiﬁc).
The ligated vector insert DNA was transformed into chemically competent cells of E.
coli One Shot TOP10 (Thermo Fisher Scientiﬁc). Transformants obtained on LB plates
containing 50 g/ml kanamycin after 24 h of incubation at 37°C were tested for the
presence of the dfrA36 gene by PCR using Taq polymerase and internal primers
dfrA36int-F (5=-GCATTTACCGGCCGATATGC-3=) and dfrA36int-R (5=-ACACGCAGCACCTC
TTCATT-3=) (annealing temperature, 56°C; extension time, 30 s). The resulting dfrA36-
containing plasmids, pT2156c19 and pT9285c17, were isolated using the PureLink
Quick plasmid miniprep kit (Thermo Fisher Scientiﬁc) and analyzed by Sanger sequenc-
ing to conﬁrm the veracity of the sequence and that dfrA36 was inserted in the opposite
direction of the TOPO promoter Plac and was therefore under the control of its own
promoter. The MIC of trimethoprim for the parent strains MF2156 and PF9285, recipient
strain TOP10, and transformant strains TOP10/pT2156c19 and TOP10/pT9285c17 was
determined on a microtiter plate using the 2-fold-dilution technique (concentration
range, 1 to 512 g/ml) following CLSI guidelines (21). The MIC for trimethoprim
increased in E. coli TOP10 expressing dfrA36 to 128 g/ml compared to the nontrans-
formed TOP10 strain (0.25 g/ml), almost reaching the level of the MIC observed in
the parent strains MF2156 and PF9285 (256 g/ml). The MIC of 13 other antibiotics was
determined using EUVSEC Sensititre plates (Thermo Fisher Scientiﬁc), showing an
association between the other antibiotic resistance genes found on strains MF2156 and
PF9285 and their phenotype (Table 1).
Spread of dfrA36 in association with ISCR2 and sul2. PCR screening of 8 addi-
tional strains from calves with no known trimethoprim resistance gene revealed dfrA36
in 5 of them. The gene was also located in these 5 strains on an ISCR2-dfrA36-sul2
fragment, as determined by Taq PCR using primers ISCR2-F (5=-CGCCTGCATTGAAGAC
CCTA-3=) and Sul2-F (5=-TGTCTGTTTCGCGCAAATCC-3=) (annealing temperature, 56°C;
extension time, 3 min). Searching for DfrA36 in the NCBI database using blastp revealed
its presence in 26 other E. coli strains as well as in an Acinetobacter sp. strain originating
from different sources (cattle, dogs, a horse, and humans) and countries, which
indicates that the dfrA36 gene has potential for dissemination among bacterial species
even if transfer could not be demonstrated experimentally. In 18 of them, the available
sequences allowed us to determine that dfrA36 was also linked to sul2, and 6 sequences
revealed the presence of the ISCR2-dfrA36-sul2 element (see Table S1 in the supple-
mental material).
This study identiﬁed a novel functional trimethoprim resistance gene (dfrA36) in E.
coli from calves. This gene appeared to be widespread in other E. coli strains as well as
in Acinetobacter, where it was also mainly directly ﬂanked by ISCR2 and/or sul2. In the
two analyzed E. coli strains from cattle, the ISCR2-dfrA36-sul2 sequence was also linked
to ﬂoR and was part of a larger multiple antibiotic and QAC resistance element. The
dissemination of this element may further jeopardize the efﬁcacy of antibiotics and
disinfectants in both veterinary and human medicine.
Accession number(s). The complete chromosome of E. coli strain PF9285 contain-
ing the 22,977-bp fragment carrying dfrA36 and ﬂanking regions (positions 989354 to
1012331) has been deposited in GenBank under accession no. CP038791 (BioProject no.
PRJNA530748).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphere.00255-19.
TABLE S1, PDF ﬁle, 0.3 MB.
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Correction for Wüthrich et al., “A Novel Trimethoprim
Resistance Gene, dfrA36, Characterized from Escherichia coli
from Calves”
Dominik Wüthrich,a Michael Brilhante,a,b Anna Hausherr,a Jens Becker,b,c Mireille Meylan,c Vincent Perretena
aInstitute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland
bGraduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland
cClinic for Ruminants, Vetsuisse Faculty, University of Bern, Bern, Switzerland
Volume 4, no. 3, e00255-19, 2019, https://doi.org/10.1128/mSphere.00255-19. The
dfrA35 gene originally described in this publication has been reclassiﬁed as dfrA36
(GenBank accession no. CP038791). The gene name has been corrected, including in
the title and the supplemental material, throughout the current version of the paper,
posted on 18 June 2019.
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